BAYER AG

BAYER AG logo
🇩🇪Germany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com
biospace.com
·

Digital Twins Could Augment Clinical Research, Help Ease Data Disparities

Digital twins, AI simulations mimicking human biological complexities, are revolutionizing healthcare by predicting treatment outcomes, streamlining clinical trials, and addressing data disparities. The global market for healthcare digital twins is projected to exceed $38 billion by 2032. Early adopters like Bayer and AstraZeneca use digital twins to enhance clinical decision-making and trial efficiency. Challenges include regulatory compliance, data quality, and the ethical implications of AI errors in healthcare.
silicon.co.uk
·

Bayer Showcases Growing Radiology Portfolio at RSNA 2024

Bayer to showcase advancements in Radiology, including AI innovations and new CT injector, at 2024 RSNA Annual Meeting. Announces collaborations with Subtle Medical, Rad AI, and AIRS Medical to expand Calantic™ Digital Solutions. Highlights new data for gadoquatrane, an investigational gadolinium-based contrast agent, and introduces AI Innovation Platform (AIIP) for healthcare AI development.
biospectrumasia.com
·

2025 Trends Buoying Boom Phase in APAC

Life sciences sector resilient despite challenges; significant investments in ADCs, CGTs, AI, and CDMOs. ADCs and CGTs driving growth, with China leading in clinical trials and innovation. AI transforming drug discovery and clinical trials. APAC region dominating clinical trials, especially in oncology. China's biopharma sector booming, attracting global investments. CDMOs adopting digital revolution and AI for agile manufacturing. BIOSECURE Act impacting Chinese biotech companies, benefiting Indian CDMOs.
nuffoodsspectrum.in
·

Thermo Fisher Scientific pioneering innovations in science and global healthcare in 2024

Thermo Fisher Scientific advances healthcare, sustainability, and precision science with FDA-approved diagnostics, microscopy innovations, sustainable packaging, ICP-MS systems, research support, global lab services, grants, partnerships, manufacturing expansions, RNA manufacturing, ultra-low temperature freezers, automated cell therapy solutions, genomic arrays, and biobased films.
genengnews.com
·

Ten Companies to Watch in AI Drug Discovery

Niven R. Narain emphasizes that AI investments in drug development require robust data and validation. GEN's A-List highlights 10 AI-based drug discovery leaders, including BPGbio, which focuses on cancer energy generation. Other notable companies include Nvidia and Palantir Technologies, though not on the A-List. The list includes specifics on companies like Anima Biotech, Atomwise, and Nimbus Therapeutics, detailing their AI platforms and drug development progress.
theglobeandmail.com
·

Gene and Cell Therapies Targeting CNS Disorders Treatment Market 2034

DelveInsight's report on the Gene and Cell Therapies Targeting CNS Disorders market forecasts growth to 2034, highlighting key companies and therapies, including Bayer AG's Phase Ib clinical trial success for Parkinson's disease and uniQure's positive trends in Huntington's disease trials. The market, valued at approximately USD 1 billion in 2021, is expected to surge due to increasing disease prevalence and pipeline product launches.
globenewswire.com
·

Antibiotics and Antimycotics Market Size to Hit $91.54 Billion, Globally at 5.2% CAGR by 2031

The antibiotics and antimycotics market is projected to reach $91.54 billion by 2031, driven by infectious disease prevalence and R&D initiatives. Key players include Pfizer, Novartis, and Sanofi. North America leads in revenue, with APAC expected to show highest growth.
genengnews.com
·

Six Companies Worthy of Note in AI Drug Discovery

BenevolentAI faces challenges with CEO departure and halted program; BioXcel advances BXCL501 in agitation treatments; BullFrog AI shows potential in liver disease and neuropsychiatric conditions; Iktos leverages AI for drug discovery; Jura Bio introduces Variational Synthesis for protein manufacturing; Phare Bio secures funding for AI-driven antibiotic discovery.
openpr.com
·

Agricultural Biotechnology Market with Business Strategy, Key

Global Agricultural Biotechnology Market to reach USD 34.2 Billion in 2023, projected to grow at CAGR 5.6% (2025-2030). Key drivers include higher crop yields, stricter pesticide regulations, biostimulant adoption, and technological advancements. Market analysis includes trends, competitor profiles, and regional insights.

Microencapsulation Market Size to Surpass USD 38.98 Bn by 2034

The global microencapsulation market is projected to grow from USD 14.47 billion in 2024 to USD 38.98 billion by 2034, driven by increased attention and benefits of the technology. North America dominated in 2023, while Asia Pacific is expected to grow fastest. Key segments include pharmaceutical and healthcare products, food and beverage, and polymer and carbohydrate coating materials. AI is impacting the market by streamlining processes and enhancing accuracy. The U.S. market is forecast to grow from USD 3.75 billion in 2024 to USD 10.31 billion by 2034.
© Copyright 2024. All Rights Reserved by MedPath